Raymond James & Associates’s Neogen NEOG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $4.21M | Buy |
250,342
+44,339
| +22% | +$730K | ﹤0.01% | 1768 |
|
|
2024
Q2 | $3.22M | Buy |
206,003
+5,753
| +3% | +$80K | ﹤0.01% | 1875 |
|
|
2024
Q1 | $3.16M | Sell |
200,250
-116,437
| -37% | -$1.95M | ﹤0.01% | 1881 |
|
|
2023
Q4 | $6.37M | Sell |
316,687
-16,462
| -5% | -$279K | ﹤0.01% | 1376 |
|
|
2023
Q3 | $6.18M | Sell |
333,149
-4,290
| -1% | -$93.4K | 0.01% | 1332 |
|
|
2023
Q2 | $7.34M | Sell |
337,439
-1,993
| -0.6% | -$36K | 0.01% | 1244 |
|
|
2023
Q1 | $6.29M | Sell |
339,432
-7,552
| -2% | -$142K | 0.01% | 1317 |
|
|
2022
Q4 | $5.28M | Buy |
346,984
+93,168
| +37% | +$1.33M | ﹤0.01% | 1361 |
|
|
2022
Q3 | $3.55M | Buy |
253,816
+119,637
| +89% | +$2.41M | ﹤0.01% | 1606 |
|
|
2022
Q2 | $3.23M | Buy |
134,179
+9,262
| +7% | +$249K | ﹤0.01% | 1697 |
|
|
2022
Q1 | $3.85M | Buy |
124,917
+3,974
| +3% | +$143K | ﹤0.01% | 1701 |
|
|
2021
Q4 | $5.49M | Sell |
120,943
-3,413
| -3% | -$146K | ﹤0.01% | 1488 |
|
|
2021
Q3 | $5.4M | Buy |
124,356
+11,077
| +10% | +$482K | ﹤0.01% | 1455 |
|
|
2021
Q2 | $5.21M | Sell |
113,279
-3,627
| -3% | -$168K | ﹤0.01% | 1465 |
|
|
2021
Q1 | $5.2M | Buy |
116,906
+6,618
| +6% | +$277K | 0.01% | 1407 |
|
|
2020
Q4 | $4.37M | Sell |
110,288
-19,402
| -15% | -$721K | ﹤0.01% | 1412 |
|
|
2020
Q3 | $5.07M | Buy |
129,690
+51,632
| +66% | +$1.98M | 0.01% | 1216 |
|
|
2020
Q2 | $3.03M | Buy |
78,058
+52,110
| +201% | +$1.76M | ﹤0.01% | 1479 |
|
|
2020
Q1 | $869K | Buy |
25,948
+4,558
| +21% | +$150K | ﹤0.01% | 2075 |
|
|
2019
Q4 | $698K | Sell |
21,390
-10,394
| -33% | -$342K | ﹤0.01% | 2499 |
|
|
2019
Q3 | $1.08M | Buy |
31,784
+9,938
| +45% | +$344K | ﹤0.01% | 2162 |
|
|
2019
Q2 | $678K | Buy |
21,846
+486
| +2% | +$14.3K | ﹤0.01% | 2462 |
|
|
2019
Q1 | $613K | Sell |
21,360
-206
| -1% | -$6.23K | ﹤0.01% | 2524 |
|
|
2018
Q4 | $615K | Buy |
21,566
+6,900
| +47% | +$216K | ﹤0.01% | 2405 |
|
|
2018
Q3 | $525K | Sell |
14,666
-30
| -0.2% | -$1.28K | ﹤0.01% | 2673 |
|
|
2018
Q2 | $589K | Buy |
14,696
+4,774
| +48% | +$176K | ﹤0.01% | 2563 |
|
|
2018
Q1 | $332K | Sell |
9,922
-2,275
| -19% | -$68.5K | ﹤0.01% | 2827 |
|
|
2017
Q4 | $376K | Hold |
12,197
| – | – | ﹤0.01% | 2711 |
|
|
2017
Q3 | $354K | Buy |
12,197
+3,517
| +41% | +$90.4K | ﹤0.01% | 2684 |
|
|
2017
Q2 | $225K | Sell |
8,680
-347
| -4% | -$8.31K | ﹤0.01% | 2916 |
|
|
2017
Q1 | $222K | Buy |
+9,027
| New | +$221K | ﹤0.01% | 2872 |
|
|
2016
Q1 | – | Sell |
-45,491
| Closed | -$964K | – | 2956 |
|
|
2015
Q4 | $964K | Sell |
45,491
-1,888
| -4% | -$38.5K | ﹤0.01% | 1655 |
|
|
2015
Q3 | $799K | Buy |
+47,379
| New | +$932K | ﹤0.01% | 1713 |
|
Other funds holding NEOG
CCA
Raymond James & Associates's NEOG Position: Q3 2024 in Review
Raymond James & Associates increased its Neogen (NEOG) stake by 22% in Q3 2024, buying an estimated $730K and bringing the position to 250,342 shares worth $4.21M. The position accounts for ﹤0.01% of the portfolio, ranked #1768.
Raymond James & Associates first reported a position in NEOG in Q3 2015 and has held it in 33 quarters since. The position peaked at $7.34M in Q2 2023. 337 funds tracked by Wall St. Rank hold NEOG as of Q3 2024.
- Raymond James & Associates held 250,342 shares of Neogen worth $4.21M as of Q3 2024.
- Raymond James & Associates bought 44,339 Neogen shares in Q3 2024, an estimated $730K.
- Neogen made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1768 holding.
- Raymond James & Associates first reported a position in Neogen in Q3 2015 and has held it in 33 quarters since.
- Raymond James & Associates's Neogen position peaked at $7.34M in Q2 2023.
- 337 funds tracked by Wall St. Rank held Neogen as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.